Intra-Cellular Therapies
ITCI
#1748
Rank
โ‚น816.60 B
Marketcap
โ‚น7,703
Share price
0.86%
Change (1 day)
72.73%
Change (1 year)

Intra-Cellular Therapies (ITCI) Fails to deliver data

Key failure to deliver metrics for Intra-Cellular Therapies:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Intra-Cellular Therapies (ITCI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Intra-Cellular Therapies (ITCI) - since 2014

Volume in USD (price x number of shares), data since 2014

Intra-Cellular Therapies (ITCI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚น4.39 M-89.58%
2023โ‚น42.15 M51.56%
2022โ‚น27.81 M16.21%
2021โ‚น23.93 M25.98%
2020โ‚น18.99 M-33.46%
2019โ‚น28.54 M2213.17%
2018โ‚น1.23 M-95.97%
2017โ‚น30.59 M29.42%
2016โ‚น23.63 M-65.91%
2015โ‚น69.33 M104.09%
2014โ‚น33.97 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚น0.01 Mโ‚น0.03 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.11 Mโ‚น1.28 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0 Mโ‚น2.24 M๐Ÿ‡บ๐Ÿ‡ธ USA